2355-16-0 Usage
Uses
Used in Pharmaceutical Industry:
2-Amino-4-[(trifluoromethyl)sulfonyl]phenylamine is used as an intermediate in the synthesis of various pharmaceuticals for its versatile chemical properties and potential therapeutic applications.
Used in Agrochemical Industry:
2-AMINO-4-[(TRIFLUOROMETHYL)SULFONYL]PHENYLAMINE is utilized as an intermediate in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals.
Used in Dye Industry:
2-Amino-4-[(trifluoromethyl)sulfonyl]phenylamine is used as a building block in the synthesis of dyes, providing a range of color options for various applications.
Used in Rubber Chemical Industry:
It is employed in the production of rubber chemicals, enhancing the properties of rubber materials for industrial and consumer products.
Used in Organic Synthesis:
2-Amino-4-[(trifluoromethyl)sulfonyl]phenylamine serves as a valuable building block for organic synthesis, enabling the creation of a wide array of chemical compounds for research and commercial purposes.
Used in Antimicrobial Agents Development:
Due to its potential antibacterial and antimicrobial properties, 2-Amino-4-[(trifluoromethyl)sulfonyl]phenylamine is used as a key ingredient in the development of new antimicrobial agents to combat resistant strains of bacteria and other microorganisms.
Check Digit Verification of cas no
The CAS Registry Mumber 2355-16-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,5 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2355-16:
(6*2)+(5*3)+(4*5)+(3*5)+(2*1)+(1*6)=70
70 % 10 = 0
So 2355-16-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H7F3N2O2S/c8-7(9,10)15(13,14)4-1-2-5(11)6(12)3-4/h1-3H,11-12H2
2355-16-0Relevant articles and documents
Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines
-
, (2008/06/13)
Substituted spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.